Tci Wealth Advisors, Inc. Seres Therapeutics, Inc. Transaction History

Tci Wealth Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$5.09 - $9.05 $2,768 - $4,923	544 New	544 $3,000
Q2 2022 Jul 19, 2022	SELL	$2.7 - $7.62 $1,401 - $3,954	-519 Closed	0 $0
Q1 2022 Apr 29, 2022	SELL	$6.3 - $8.84 $81 - $114	-13 Reduced 2.44%	519 $4,000
Q4 2021 Jan 24, 2022	BUY	$6.02 - $11.43 $3,202 - $6,080	532 New	532 $4,000
Q3 2021 Oct 29, 2021	SELL	$5.46 - $22.6 $742 - $3,073	-136 Closed	0 $0
Q2 2021 Aug 02, 2021	BUY	$18.46 - $24.36 $812 - $1,071	44 Added 47.83%	136 $3,000
Q1 2021 Apr 29, 2021	BUY	$17.66 - $28.92 $1,624 - $2,660	92 New	92 $2,000

46.3M

119K

466K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $114M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.